The fragile cytoskeleton was attributed to an alteration of TGFβ pathways in HHT patients where a decreased Eng expression or impaired ALK1–ALK5 signaling were found, but other possible mechanisms were not considered. The gene discussed is TGFB1; the disease is hereditary hemorrhagic telangiectasia.